{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:14:13Z","timestamp":1787508853855,"version":"build-2736575974"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijcard.2016.06.311","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T03:54:32Z","timestamp":1467518072000},"page":"14-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Severe left ventricular hypertrophy and marked cardiac fibrosis in Danon disease"],"prefix":"10.1016","volume":"221","author":[{"given":"Michael B.","family":"Stokes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona A.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen E.","family":"D'Arcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijcard.2016.06.311_bb0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/WNL.31.1.51","article-title":"Lysosomal glycogen storage disease with normal acid maltase","volume":"31","author":"Danon","year":"1981","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ijcard.2016.06.311_bb0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/jhg.2012.72","article-title":"Danon disease: focusing on heart","volume":"57","author":"Cheng","year":"2012","journal-title":"J. Hum. Genet."},{"issue":"11","key":"10.1016\/j.ijcard.2016.06.311_bb0015","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1177\/0883073810367683","article-title":"End-stage cardiac disease as an initial presentation of systemic myopathies: case series and literature review","volume":"25","author":"Katzberg","year":"2010","journal-title":"J. Child Neurol."},{"issue":"8","key":"10.1016\/j.ijcard.2016.06.311_bb0020","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/hrt.2003.029504","article-title":"Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey","volume":"90","author":"Charron","year":"2004","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ijcard.2016.06.311_bb0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ijcard.2016.06.311_bb0030","first-page":"594","article-title":"Clinical characterization of patients with Danon disease","volume":"41","author":"He","year":"2013","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"6","key":"10.1016\/j.ijcard.2016.06.311_bb0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/GIM.0b013e31820ad795","article-title":"Natural history of Danon disease","volume":"13","author":"Boucek","year":"2011","journal-title":"Genet. Med."},{"issue":"9","key":"10.1016\/j.ijcard.2016.06.311_bb0040","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/jce.12142","article-title":"Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy","volume":"24","author":"Zaki","year":"2013","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2016.06.311_bb0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nmd.2004.12.007","article-title":"Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease)","volume":"15","author":"Lobrinus","year":"2005","journal-title":"Neuromuscul. Disord."},{"issue":"6","key":"10.1016\/j.ijcard.2016.06.311_bb0050","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnen\/64.6.513","article-title":"Autophagic vacuoles with sarcolemmal features delineate Danon disease and related myopathies","volume":"64","author":"Sugie","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"10","key":"10.1016\/j.ijcard.2016.06.311_bb0055","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10038-007-0184-8","article-title":"Danon disease presenting with dilated cardiomyopathy and a complex phenotype","volume":"52","author":"Taylor","year":"2007","journal-title":"J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.ijcard.2016.06.311_bb0060","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00431-005-1678-z","article-title":"Familial X-linked cardiomyopathy (Danon disease): diagnostic confirmation by mutation analysis of the LAMP2gene","volume":"164","author":"Balmer","year":"2005","journal-title":"Eur. J. Pediatr."},{"issue":"12","key":"10.1016\/j.ijcard.2016.06.311_bb0065","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.2009.371","article-title":"Clinical outcome and phenotypic expression in LAMP-2 cardiomyopathy","volume":"301","author":"Maron","year":"2009","journal-title":"JAMA"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316313237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316313237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T15:30:31Z","timestamp":1536593431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316313237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":13,"alternative-id":["S0167527316313237"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.311","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe left ventricular hypertrophy and marked cardiac fibrosis in Danon disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}